Cryptococcal meningitis – Page 3

Diagnostic Capacity for Fungal Infections in Tertiary Hospitals in Nigeria and Ghana – An Onsite Baseline Audit of 9 Sites

mycolabadmin

Researchers audited laboratory facilities in 9 major hospitals (8 in Nigeria, 1 in Ghana) to see how well they could test for fungal infections. They found that most hospitals lacked basic equipment, trained staff, and proper procedures for fungal testing. This is a serious problem because fungal infections can be deadly if not caught early and treated quickly.

Cryptococcus: Emerging host risk factors for infection

mycolabadmin

This scientific review examines why some people without HIV are getting serious Cryptococcus infections and becoming very sick. Researchers found that people with liver problems, kidney disease, diabetes, cancer, and autoimmune diseases face much higher risk. The review also identifies new drugs and therapies that can surprisingly increase infection risk, highlighting the importance of understanding individual patient factors when treating these dangerous fungal infections.

Antifungal Activity of Selected Naphthoquinones and Their Synergistic Combination with Amphotericin B Against Cryptococcus neoformans H99

mycolabadmin

Researchers tested five compounds called naphthoquinones for their ability to fight a dangerous fungal infection called cryptococcosis. They found that one compound called 2-MNQ works especially well when combined with the standard antifungal drug amphotericin B, making the treatment more effective. This discovery could lead to better treatments for people with weakened immune systems who are vulnerable to this infection.

Emerging Infections Network Survey of Screening for Cryptococcal Antigenemia, United States, 2024

mycolabadmin

Researchers surveyed infectious disease doctors across the United States about their use of a simple blood test that detects cryptococcal fungal infections in HIV patients before symptoms appear. The test, called cryptococcal antigen (CrAg) screening, can prevent serious illness and death if caught early, but the survey found that many doctors are not using it consistently. About 42% of doctors were unsure about the benefits of the test, and another 32% were confused about current screening recommendations, revealing a need for better education about this important preventive tool.

Clinical spectrum, immune status, and prognostic factors of cryptococcosis: insights from a large, multi-center, ambispective cohort study in southeastern China

mycolabadmin

This study examined cryptococcosis, a serious fungal infection, in 396 non-HIV patients across hospitals in southeastern China. The researchers found that patients’ immune status, whether the infection spread to the brain, and blood inflammation markers were key predictors of survival. Most patients treated with azole medications (a common antifungal) improved or recovered, though those with brain involvement or severe immune deficiency had worse outcomes. The findings help doctors identify which patients need more intensive treatment.

Antifungal Policy and Practice Across Five Countries: A Qualitative Review

mycolabadmin

This study examines how well five different countries handle invasive fungal infections through their healthcare policies and systems. Researchers found that while these infections affect millions of people globally, most countries lack comprehensive policies to diagnose, treat, and manage them effectively. Major issues include inadequate healthcare provider training, limited access to rapid diagnostic tests, and insufficient antifungal medications in some regions. The study recommends that countries develop better national strategies for preventing, diagnosing, and treating these serious infections.

Breaking down biofilms across critical priority fungal pathogens: proteomics and computational innovation for mechanistic insights and new target discovery

mycolabadmin

This comprehensive review examines how scientists are fighting dangerous fungal infections that form protective biofilms resistant to current antifungal drugs. Researchers are using advanced protein analysis techniques (proteomics) and artificial intelligence-based computational tools to identify new targets for drug development against four critical fungal pathogens that cause life-threatening infections like meningitis and lung infections. By combining these technologies, scientists can better understand how these fungal biofilms form and develop more effective treatments.

Effects of simulated microgravity on biological features and virulence of the fungal pathogen Cryptococcus neoformans

mycolabadmin

Scientists studied how a dangerous fungus called Cryptococcus neoformans behaves in space-like conditions. They found that in simulated microgravity, this fungus becomes more dangerous by developing thicker protective capsules, producing more protective pigment, and becoming more deadly to organisms in laboratory models. This research is important because astronauts in space have weaker immune systems, making them vulnerable to infections from fungi that may have adapted to thrive in space environments.

Is Cryptococcus neoformans a pleomorphic fungus?

mycolabadmin

Cryptococcus neoformans is a dangerous fungal pathogen that causes serious infections in humans. For many years, scientists thought this fungus existed primarily as regular yeast cells. However, new research shows the fungus can change into several different cell forms during infection, including larger ‘titan cells’ and smaller ‘seed cells.’ These shape-shifting abilities help the fungus survive in the human body and evade immune responses, making infections harder to treat.

Awareness and perception of invasive fungal diseases among the Nigerian population

mycolabadmin

This study found that very few Nigerians (only about 19%) are aware of serious fungal infections like candidiasis and aspergillosis, and most people don’t understand how dangerous these diseases can be. The researchers surveyed over 1,200 people and discovered that people with more education and higher incomes were more likely to know about these infections. The findings suggest that Nigeria urgently needs public health campaigns and education programs to help people recognize fungal diseases early so they can get proper treatment.

Disease: Cryptococcal meningitis